Suchergebnisse - "Takakura, Toshiaki"

PubPharm (7)

1

Neoadjuvant nivolumab plus chemotherapy followed by resection for superior sulcus tumour with high PD-L1 expression : A case report

enthalten in: Respirology case reports | 2024

von Nakaya, T. | Hirai, Y. | Akamatsu, H. | +9

2

Mannitol versus furosemide in patients with thoracic malignancies who received cisplatin-based chemotherapy using short hydration : A randomized phase II trial

enthalten in: Cancer medicine | 2024

von Murakami, E. | Akamatsu, H. | Teraoka, S. | +15

3

Mannitol versus furosemide in patients with thoracic malignancies who received cisplatin‐based chemotherapy using short hydration : A randomized phase II trial

enthalten in: Cancer Medicine | 2024

von Murakami, E. | Akamatsu, H. | Teraoka, S. | +15

4

Treatment of Non-Small Cell Lung Cancer with HER2 Alterations

enthalten in: Gan to kagaku ryoho. Cancer & chemotherapy | 2023

von Takakura, T. | Yamamoto, N.

5

Efficacy of Crizotinib After Entrectinib Resistance Due to MET Polysomy in ROS1-Rearranged NSCLC : A Case Report

enthalten in: JTO clinical and research reports | 2023

von Takakura, T. | Kanemura, H. | Sakai, K. | +3

6

CD24, not CD47, negatively impacts upon response to PD-1/L1 inhibitors in non-small-cell lung cancer with PD-L1 tumor proportion score < 50

enthalten in: Cancer science | 2021

von Ozawa, Y. | Harutani, Y. | Oyanagi, J. | +18

7

CD24, not CD47, negatively impacts upon response to PD‐1/L1 inhibitors in non–small‐cell lung cancer with PD‐L1 tumor proportion score < 50

enthalten in: Cancer Science | 2021

von Ozawa, Y. | Harutani, Y. | Oyanagi, J. | +18

1
[1]